American Century Companies’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
101,614
+44,052
+77% +$146K ﹤0.01% 2676
2026
Q1
$206K Buy
+57,562
New +$229K ﹤0.01% 2705
2024
Q1
Sell
-8,370
Closed -$251K 2955
2023
Q4
$251K Buy
+8,370
New +$185K ﹤0.01% 2628
2021
Q1
Sell
-22,755
Closed -$1.25M 2246
2020
Q4
$1.25M Buy
+22,755
New +$830K ﹤0.01% 1196

Other funds holding RCKT

American Century Companies's RCKT Position: Q2 2026 in Review

American Century Companies increased its Rocket Pharmaceuticals (RCKT) stake by 77% in Q2 2026, buying an estimated $146K and bringing the position to 101,614 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

American Century Companies first reported a position in RCKT in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.25M in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • American Century Companies held 101,614 shares of Rocket Pharmaceuticals worth $348K as of Q2 2026.
  • American Century Companies bought 44,052 Rocket Pharmaceuticals shares in Q2 2026, an estimated $146K.
  • Rocket Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2676 holding.
  • American Century Companies first reported a position in Rocket Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • American Century Companies's Rocket Pharmaceuticals position peaked at $1.25M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.